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Traditionally, the Wellcome Trust has either funded medical and scientific research that looks to 
the future, or else medical history research that looks to the past. The Trust plans to bridge 
several gaps with a new research programme: gaps between past and future, and between a range 
of disciplines. Now in its early planning stages, the £1 million programme on ethical and social 
issues, probably in genetic and neuro-scientific research, will examine current and future 
questions and dilemmas. It will bring together researchers from a range of disciplines in science, 
social science, law and philosophy.  During January 1998, about 40 people met to discuss 
possible topics, methods, aims and disciplines to be considered for the programme.  Those 
present - such as scientists, clinicians, leading people in law, philosophy and policy, journal 
editors, and the chief executives of two research councils - were taken to represent “providers” of 
ethical research, “users” of the research or funders.  
  I was invited as a “user” in being a member of CERES. CERES  aims to bring together all kinds 
of groups and professions concerned with medical research, who seldom meet, to enable them to 
exchange ideas and thereby to help to raise standards and mutual understanding. The only agreed 
CERES policy is that consumers/health service users should be more fully involved at every 
stage of research from inception and selection of projects to disseminating and implementing the 
findings.  
  For two days, we debated whether there is a small or large group of social researchers (meaning 
the 20 or so disciplines covered by the Economic and Social Research Council, ESRC) and 
bioethical researchers willing and able to work on neuroscience or genetics. Some said there are 
too few social researchers to merit a large grants programme. Some said that applications to a 
planned Medical Research Council programme on social aspects of genetics a few years ago were 
too weak to be worth funding. Others said there are, or could be, many more competent social 
researchers in these areas, if only they could get funding and crawl out of the cracks or chasms 
between all the funding bodies which now entrap them. They include researchers working in 
areas closely related to genetics, such as kinship, living with disability or chronic illness, and 
reproductive health, and to neuro-science in many aspects of mental health. The ESRC also plans 
to set up a related £1 million programme, a promising start, although these are tiny amounts in 
comparison with the billions of dollars granted in the US to address social and ethical questions 
raised by genetics and neuroscience developments.  
  It is likely to be months before applications are invited. Meanwhile, researchers planning to 
apply could do some ground work to strengthen their research proposals. The Trustees are likely 
to favour inter-disciplinary research, so that it is worth beginning to form networks between 
clinicians, social scientists and law and ethics centres. Some inter-disciplinary liaison over 
selected topics and research theories and methods is likely to be necessary. It may take several 
meetings to agree on research designed to produce clear, practical findings and also theoretical 
analysis. Research teams may need to debate the appropriate compromise for social researchers 
between knowing too little about the relevant clinical specialty, and knowing so much that they 
lose an independent perspective. Another fine line to work on is the place of overt theorising in 
research: between seeming to exploit the research mainly to support theoretical work of no 
obvious practical relevance, or else of producing atheoretical telephone directory style reports.  
  The Wellcome Trust and the ESRC will favour research which involves “users” like health 
policy makers, related voluntary organisations, and members of related medical, nursing, 
counselling or advocacy groups. It is worth involving some in the research network to support 
and inform the project. Depressing gaps were revealed during the Wellcome meeting, when 
doctors would say, “We need research about ---, no one’s done any.” The few researchers would 
sigh and say, “A lot has been done but we cannot get our reports into your journals.” The journal 
editors complained that papers submitted were too crude or too soft. Gaps to be bridged became 
clearer through the meeting, between disciplines and specialties, and between different research 
theories and methods. We discussed how funders and also reviewers for grant giving bodies and 
for scientific and clinical journals can become more receptive to social and ethical research. 
Some open meetings may be held while the Wellcome programme is being designed. These 
could be useful if they move beyond introductory lectures to critical inter-disciplinary debates.  
  One question for debate is: Who are the consumers of bioethics research? Are they primarily 
researchers and their funders and policy makers who are influenced by bioethics insights? Are 
research subjects the indirect beneficiaries rather than the actual consumers? Or is it envisaged 
that lay people could use bioethics research reports to support and further their own concerns 
about genetic and neroscience research? If a quasi-market is being promoted what might be its 
ethical basis?  
  CERES is a forum for many ‘minority’ groups who together make up a large proportion of UK 
society. Some genetic conditions are exclusive to, or especially common among, certain ethnic 
minorities and at our meetings they question the appropriateness of much mainstream research, 
not only to people in the UK but also to those in the poorer majority world. A few general and 
repeatedly made points from CERES meetings include these following concerns.  
  Bioethics is seen as frequently abstract and intellectually elitist. It tends to discount knowledge 
gained through personal experience  and to favour scientific and medical accounts. Its selective 
views bias its relations with medial and scientific research in three main ways.  
1.  In theory, by favouring intellectual analysis over personal experience, bioethics inevitably 
shapes its arguments towards certain conclusions and in doing so tends to reflect and reinforce 
the medical pathologising of disability, of chronic illness such as diabetes, and of learning 
difficulties. (How many people with diabetes see themselves as ill, or people with learning 
difficulties feel that their life is not worth living?)  One, from many examples of anti-disability 
language and assumptions, is the Report of the Committee of the Ethics of Gene Therapy, 1990. 
2.  In policy, bioethics tends to concentrate on personal individual perspectives, respect for the 
autonomy of the research subject, or for the putative autonomy of the person healed of conditions 
such as cystic fibrosis. Distributive justice and the politics and economics of genetic research 
appear scarcely to be debated by ethicists, though these are of great concern to those who attend 
CERES meetings. They frequently debate the preferences of affected people for simple 
inexpensive treatments, and the pressures on researchers to develop high-technology very costly 
treatments. There is concern that the government’s concern for profitable research outcomes, and 
the pharmaceutical industry’s all-pervading influence in health care and research drive much 
research into inappropriate directions. 
3.  In practice, by claiming to be the most informed and relevant non-scientific commentators on 
genetic research, bioethicists fill the places in publica debates and on ethics committees which 
could be taken by, or at least shared with, people with more direct and critical experiences  and 
concerns. At times, bioethicists appear to collude with researchers to end critical protests and to 
‘reassure’ the public, for example, through ethics committees set up by the MRC such as the 
recent one on intelligence trials. 
  These concerns raise questions about how bioethicists perceive their relationship with genetic 
and neuroscience researchers - as supporters, collaborators or somewhat independent critics? 
How do they perceive their relationships with ‘users’ who are not only carers but also people who 
have the full genetic conditions? How do bioethicists consider that they serve society, and what 
do they mean by society and its best interests? What does and should bioethics research be like - 
analytical, textual, reflexive, politically engaged, empirical, theoretical? I hope these questions 
will be examined during the forthcoming research programmes. 
  
